NYSE
$27.80▲ 0.45%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $6.43BShares out 2.300M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
43- 10.15After-hours26.10.16 05:444Ownership#●●●
Hims & Hers Health, Inc.
Insider Boughton Soleil of Hims & Hers Health, Inc. reported changes in beneficial ownership of securities effective October 14, 2026. This filing is a standard Form 4 statement regarding insider equity transactions.…more
$27.80+0.45%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.15After-hours26.10.16 05:443Ownership
Hims & Hers Health, Inc.
Jonathan M. Franklin, an insider at Hims & Hers Health, Inc., has filed a Power of Attorney to delegate SEC reporting responsibilities to designated attorneys-in-fact. This filing authorizes these representatives to manage EDGAR account activities and execute required filings under Section 13 and Section 16 of the Exchange Act on his behalf.…more
$27.80+0.45%vs prev closeView filingShare - 10.14Regular26.10.14 22:44144Ownership
Hims & Hers Health, Inc.
Boughton Soleil, an insider at Hims & Hers Health, Inc., filed a Form 144 with the SEC on October 14, 2026, to report a plan for the sale of securities. This filing represents a standard notification of an insider's intent to dispose of shares.…more
$27.80+0.45%vs prev closeView filingShare
42 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 1d agoRegular26.10.24 02:26#●●●
Hims & Hers Seeks Dismissal of Consumer Deception Lawsuit
Hims & Hers has urged the court to dismiss a consumer deception lawsuit, asserting that it provided clear disclosures regarding data privacy and subscription billing. The company maintains that all users must acknowledge its policies, which explicitly outline data sharing and recurring payment terms, prior to purchase.…more
$27.80+0.45%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 2d agoRegular26.10.23 04:22
●●●●●●●● ●●●●● ●●●●●●
Hims & Hers has filed a motion to dismiss a lawsuit brought by the FTC regarding its user data practices and subscription models. This legal move comes as the company faces ongoing regulatory scrutiny over its business operations.…more
$27.80+0.45%vs prev closeShareBenzinga - 3d agoPre-market26.10.21 21:22
●●●●●●●● ●●●●● ●●●●●●
Telehealth platform Hims has launched new injectable and oral treatments for testosterone replacement therapy. While this expands the company's product portfolio, the lack of specific financial guidance or profit projections leads to a neutral outlook.…more
$27.80+0.45%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report